CUSIP 75955J402COMRLMDQ4 2025
41 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Janus Henderson Group PLC | 7.27M | $35.04M |
| 2 | Squadron Capital Management LLC | 6.70M | $32.36M |
| 3 | Adage Capital Partners Gp, L.L.C. | 4.27M | $20.62M |
| 4 | Spruce Street Capital LP | 4.09M | $19.74M |
| 5 | Marshall Wace, LLP | 3.19M | $15.41M |
| 6 | Ikarian Capital, LLC | 3.07M | $14.82M |
| 7 | Orbimed Advisors LLC | 2.61M | $12.61M |
| 8 | Ameriprise Financial Inc | 1.92M | $9.27M |
| 9 |
| 4 | Feb 6, 2026 | Janus Henderson Group PLC | 13G | 10.1% | 7.44M | SEC |
| 5 | Nov 14, 2025 | Ikarian Capital, LLC | 13G | 11.0% | 3.54M | SEC |
| 6 | Aug 14, 2025 | Squadron Master Fund LP | 13G/A | 9.9% | 3.30M | SEC |
| 7 | May 1, 2025 | Squadron Master Fund LP | 13G | 6.2% | 2.05M | SEC |
| 8 | Nov 14, 2024 | Deep Track Capital, LP | 13G/A | 2.2% | 674.8K | SEC |
| 9 | Mar 6, 2024 | Perceptive Advisors LLC | 13G/A | — | — | SEC |
| 10 | Feb 14, 2024 | Deep Track Capital, LP | 13G/A | 6.8% | 2.04M | SEC |
See the full Schedule 13D/13G history for Relmada Therapeutics Inc.
Unlock full history| Driehaus Capital Management LLC |
| 1.88M |
| $9.08M |
| 10 | Millennium Management LLC | 1.67M | $8.08M |